Biotricity, Inc.
BTCY · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 14.3% | 25.2% | 26% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 76.6% | 69.3% | 56.5% | 59.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -23.3% | -73.7% | -166.7% | -242.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -61.1% | -116.8% | -193.6% | -380.8% |
| EPS Diluted | -0.55 | -1.66 | -2.26 | -3.99 |
| % Growth | 66.9% | 26.5% | 43.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |